ReviewWorld journal of cardiology2021

Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.

Mouhamed Nashawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.